Table 4 Baseline characteristics of patients with and without hypertension
Before PSM | After PSM | |||||
|---|---|---|---|---|---|---|
Non-hypertension (n = 142) | Hypertension (n = 84) | P-value | Non-hypertension (n = 54) | Hypertension (n = 54) | P-value | |
Males (%) | 62 (42.66%) | 51 (60.71%) | 0.019 | 31 (57.71%) | 30 (55.56%) | 1.000 |
Age (years) | 46.73 (15.20) | 65.99 (12.81) | < 0.001 | 60.61 (11.64) | 62.93 (13.74) | 0.347 |
Onset time (day) | 7.08 (4.00–10.00) | 6.92 (4.00–9.75) | 0.751 | 7.63 (4.27) | 7.15 (4.25) | 0.558 |
T2DM (%) | 11 (7.75%) | 34 (40.48%) | < 0.001 | 9 (16.67%) | 15 (27.78%) | 0.247 |
CHD (%) | 5 (3.52%) | 8 (9.52%) | 0.078 | 5 (9.26%) | 5 (9.26%) | 1.000 |
COPD (%) | 2 (1.41%) | 4 (4.76%) | 0.198 | 2 (3.70%) | 2 (3.70%) | 1.000 |
WBC (109) | 4.89 (3.63–5.90) | 5.90 (4.21–7.27) | 0.013 | 5.29 (4.01–7.15) | 4.90 (3.66–6.16) | 0.285 |
N/L | 2.83 (1.61–5.07) | 4.88 (2.95–7.78) | < 0.001 | 5.22 (3.27–7.72) | 3.96 (2.17–6.49) | 0.05 |
ALT (U/L) | 19.80 (13.60–33.43) | 20.75 (14.20–31.80) | 0.766 | 25.65 (16.13–36.60) | 24.65 (16.00–36.90) | 0.649 |
AST (U/L) | 21.00 (16.88–32.85) | 26.85 (20.78–40.68) | 0.008 | 32.15 (19.13–51.13) | 25.90 (20.63–39.70) | 0.197 |
ALB (g/L) | 39.60 (5.27) | 36.44 (4.70) | < 0.001 | 36.63 (4.96) | 37.54 (4.44) | 0.319 |
sCr (μmol/L) | 64.90 (52.08–74.43) | 74.35 (57.63–99.40) | 0.001 | 71.55 (58.93–82.18) | 72.05 (57.15–92.40) | 0.792 |
BUN (mmol/L) | 3.93 (3.07–5.02) | 5.58 (3.66–8.09) | < 0.001 | 4.97 (3.75–6.43) | 4.90 (3.62–7.14) | 0.578 |
CRP (mg/dL) | 1.16 (0.16–4.55) | 6.10 (2.35–8.42) | < 0.001 | 4.74 (2.53–6.74) | 4.13 (1.52–7.16) | 0.541 |
D-dimer (μg/mL) | 0.52 (0.25–1.54) | 1.44 (0.62–6.81) | < 0.001 | 1.21 (0.50–8.59) | 1.31 (0.61–6.57) | 0.719 |